Abetimus

Active ingredient description

Abetimus is a selective immunosuppressive agent (a compound that selectively dampens down the immune system). Most patients with SLE have antibodies in their blood that are directed against double-stranded DNA (deoxyribonucleic acid). These antibodies are thought to be linked to the development of lupus kidney disease. Abetimus is a small piece of double-stranded DNA that has been designed to reduce circulating levels of these antibodies. When Abetimus is injected, the levels of these antibodies in the blood are lowered and this is expected to help reduce the patient’s likelihood of experiencing a ‘flare’.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Abetimus
L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants
Discover more medicines within L04AA22

Unique ingredient identifier (UNII)

P3UVQ22SHK - ABETIMUS

CAS registry number

167362-48-3 - abetimus